| Dr Michelle Olivette Clark, MD | |
|
1005 Atlantic Ave, Alameda, CA 94501-1148 | |
| (415) 474-7310 | |
| Not Available |
| Full Name | Dr Michelle Olivette Clark |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1005 Atlantic Ave, Alameda, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164551545 | NPI | - | NPPES |
| A 31665 | Other | CA | STATE MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | A 31665 (California) | Primary |
| Entity Name | Alameda Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740332931 PECOS PAC ID: 3779494521 Enrollment ID: O20031110000764 |
News Archive
The current COVID-19 pandemic began as a zoonosis in China, at the end of 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel betacoronavirus with significant similarity to an earlier virus of the same family.
Parents, teachers and others can find it hard to spot signs of depression and anxiety in children - and struggle with how they can help.
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today provided further updates on the business development of its flagship product: Gingko Mihuan Oral Liquid with the SFDA approval number: H20013079.
On the eve of the World Hepatitis Summit in Brazil, WHO reports increasing global momentum in the response to viral hepatitis. A record 3 million people were able to obtain treatment for hepatitis C over the past two years, and 2.8 million more people embarked on lifelong treatment for hepatitis B in 2016.
› Verified 8 days ago
| Entity Name | Felton Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144551581 PECOS PAC ID: 7719025550 Enrollment ID: O20091116000112 |
News Archive
The current COVID-19 pandemic began as a zoonosis in China, at the end of 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel betacoronavirus with significant similarity to an earlier virus of the same family.
Parents, teachers and others can find it hard to spot signs of depression and anxiety in children - and struggle with how they can help.
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today provided further updates on the business development of its flagship product: Gingko Mihuan Oral Liquid with the SFDA approval number: H20013079.
On the eve of the World Hepatitis Summit in Brazil, WHO reports increasing global momentum in the response to viral hepatitis. A record 3 million people were able to obtain treatment for hepatitis C over the past two years, and 2.8 million more people embarked on lifelong treatment for hepatitis B in 2016.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Olivette Clark, MD 4100 Redwood Rd Ste 20a-522, Oakland, CA 94619-2363 Ph: (510) 842-8960 | Dr Michelle Olivette Clark, MD 1005 Atlantic Ave, Alameda, CA 94501-1148 Ph: (415) 474-7310 |
News Archive
The current COVID-19 pandemic began as a zoonosis in China, at the end of 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel betacoronavirus with significant similarity to an earlier virus of the same family.
Parents, teachers and others can find it hard to spot signs of depression and anxiety in children - and struggle with how they can help.
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today provided further updates on the business development of its flagship product: Gingko Mihuan Oral Liquid with the SFDA approval number: H20013079.
On the eve of the World Hepatitis Summit in Brazil, WHO reports increasing global momentum in the response to viral hepatitis. A record 3 million people were able to obtain treatment for hepatitis C over the past two years, and 2.8 million more people embarked on lifelong treatment for hepatitis B in 2016.
› Verified 8 days ago
Dr. Claudine Gabriella Dutaret, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2070 Clinton Ave Dept, Alameda, CA 94501 Phone: 510-522-3700 Fax: 888-375-2135 | |
Kent C Eller, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1080 Marina Village Pkwy Ste 100, Alameda, CA 94501 Phone: 103-377-9505 Fax: 602-685-3808 | |
Edward Leon Kaftarian, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1080 Marina Village Pkwy Ste 100, Alameda, CA 94501 Phone: 415-279-3879 | |
Robyn G Young, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 985 Atlantic Ave, Suite 300, Alameda, CA 94501 Phone: 510-748-5363 | |
Dr. Christopher K Wood, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Telecare Corp, 1080 Marina Village Pkwy, Alameda, CA 94501 Phone: 209-300-8800 | |
Barbara A Mcquinn, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 985 Atlantic Ave, Suite 300, Alameda, CA 94501 Phone: 510-748-5363 Fax: 510-748-5425 |